Handelsbanken Fonder
XENE icon

Handelsbanken Fonder’s Xenon Pharmaceuticals XENE Stock Holding History

Handelsbanken Fonder’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Hold
29,800
– – 0.01% 853
2026
Q1 		$1.73M Hold
29,800
– – 0.01% 799
2025
Q4 		$1.34M Buy
29,800
+7,100
+31% +$298K ﹤0.01% 911
2025
Q3 		$911K Hold
22,700
– – ﹤0.01% 1042
2025
Q2 		$711K Hold
22,700
– – ﹤0.01% 1098
2025
Q1 		$762K Hold
22,700
– – ﹤0.01% 1058
2024
Q4 		$890K Hold
22,700
– – ﹤0.01% 1025
2024
Q3 		$894K Buy
22,700
+1,700
+8% +$68.5K ﹤0.01% 994
2024
Q2 		$819K Buy
21,000
+6,900
+49% +$276K ﹤0.01% 921
2024
Q1 		$607K Hold
14,100
– – ﹤0.01% 1070
2023
Q4 		$649K Hold
14,100
– – ﹤0.01% 999
2023
Q3 		$482K Hold
14,100
– – ﹤0.01% 1070
2023
Q2 		$543K Hold
14,100
– – ﹤0.01% 1027
2023
Q1 		$505K Hold
14,100
– – ﹤0.01% 1004
2022
Q4 		$556K Buy
14,100
+3,500
+33% +$127K ﹤0.01% 915
2022
Q3 		$383K Sell
10,600
-4,600
-30% -$165K ﹤0.01% 1106
2022
Q2 		$462K Sell
15,200
-2,400
-14% -$72.6K ﹤0.01% 1072
2022
Q1 		$538K Sell
17,600
-3,100
-15% -$92.8K ﹤0.01% 1150
2021
Q4 		$647K Buy
+20,700
New +$619K ﹤0.01% 1175

Other funds holding XENE

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Handelsbanken Fonder's XENE Position: Q2 2026 in Review

Handelsbanken Fonder held its Xenon Pharmaceuticals (XENE) position steady in Q2 2026 at 29,800 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #853.

Handelsbanken Fonder first reported a position in XENE in Q4 2021 and has held it in 19 quarters since. 46 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Handelsbanken Fonder held 29,800 shares of Xenon Pharmaceuticals worth $1.8M as of Q2 2026.
  • Handelsbanken Fonder left its Xenon Pharmaceuticals share count unchanged in Q2 2026.
  • Xenon Pharmaceuticals made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #853 holding.
  • Handelsbanken Fonder first reported a position in Xenon Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 46 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.